Latest Breaking News On - மங்கலான ஷா - Page 1 : comparemela.com
Covishield vaccination accepted in Switzerland, 7 EU countries
Nearly 95 per cent of people with cancer developed a good immune response to the Covid-19 mRNA vaccines three to four weeks after receiving their second dose, finds a new study co-authored by Indian-origin researchers.
The study, published in the journal Cancer Cell, indicated that among the 131 patients studied, 94 per cent developed antibodies to the coronavirus.
Seven high-risk patients did not.
Russia Coronavirus Vaccine
YouTube Grab/Sputnik We could not find any antibodies against the virus in those patients, said researcher Dimpy P. Shah from the University Of Texas Health Science Center at San Antonio.
Geneva
Genè
Switzerland
Russia
Texas
United-states
Dimpyp-shah
Dimpy-shah
Pankilk-shah
Texas-health-science-center-at-san-antonio
Geneva-university-hospital
Cancer-cell